A long-established medical cannabis clinic and research organisation in Canada has begun recruitment for a study of patient outcomes from personalised medical cannabis treatment plans.
A new scientific review on cannabis and cancer concludes that a variety of cannabinoids—including delta-9 THC, CBD and cannabigerol (CBG)—”show promising potential as anticancer agents
With Oct. 17 marking the sixth anniversary of Canada’s legalization of recreational cannabis, a Brock researcher says it’s time to examine how the process has impacted the medical cannabis market.
The U.S. government recently proposed rescheduling cannabis from a Schedule I to a Schedule III drug — basically signaling it has some accepted medical use
A review of research into the synergistic effects of the chemical components in medical marijuana—an idea commonly known as the entourage effect—says that terpenes